Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange

Blood

Volumn 100, Issue 7, 2002, Pages 2472-2478

  Lahav, Judith ^a,b,c   Jurk, Kerstin ^a,b,c   Hess, Oded ^a,b,c   Barnes, Michael J ^a,b,c   Farndale, Richard W ^a,b,c   Luboshitz, Jacob ^a,b,c   Kehrel, Beate E ^a,b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CHLOROMERCURIBENZENESULFONIC ACID; DISULFIDE; FIBRINOGEN RECEPTOR; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RL90; PADGEM PROTEIN; PROTEIN DISULFIDE ISOMERASE; THIOL DERIVATIVE; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; CATALYSIS; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME CONFORMATION; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0036786353     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0339     Document Type: Article

References (41)

1. Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol. 1998;8:359-364.
2. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91:2645-2657.
3. Bazzoni G, Hemler ME. Are changes in integrin affinity and conformation overemphasized? Trends Biochem Sci. 1998;23:30-34.
4. Parise LV. Integrin αIIbβ signaling in platelet adhesion and aggregation. Curr Opin Cell Biol. 1999;11:597-601.
5. Coppolino MG, Dedhar S. Bi-directional signal transduction by integrin receptors. Int J Biochem Cell Biol. 2000;32:171-188.
6. Oxvig C, Lu C, Springer TA. Conformational changes in tertiary structure near the ligand-binding site of an integrin I domain. Proc Natl Acad Sci U S A. 1999;96:2215-2220.
7. Calvete JJ. Platelet integrin GPIIb/IIIa: structure-function correlations: an update and lessons from other integrins. Proc Soc Exp Biol Med. 1999;222:29-38.
8. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin α2β1. Cell. 2000;100:47-76.
9. Yan B, Hu DD, Knowles SK, Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet integrin αIIbβ3. J Biol Chem. 2000;275:7249-7260.
10. Woodside DG, Liu S, Ginsberg MH. Integrin activation. Thromb Haemost. 2001;86:316-323.
11. Phillips DR, Nannizzi-Alaimo L, Prasad KS. β3 tyrosine phosphorylation in αIIbβ3 (platelet membrane GP IIb-IIIa) outside-in signaling. Thromb Haemost. 2001;86:246-258.
12. Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost. 2001;86:198-213.
13. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;286:1028-1032.
14. Gofer-Dadosh N, Klepfish A, Schmilowitz H, Shaklai M, Lahav J. Affinity modulation in α2β1 following ligand binding. Biochem Biophys Res Commun. 1997;232:724-727.
15. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett. 2000;475:89-92.
16. Schwartz BR, Harlan JM. Sulfhydryl reducing agents promote neutrophil adherence without increasing surface expression of CD11b/CD18. Biochem Biophys Res Commun. 1989;169:51-57.
17. Schwartz BR, Harlan JM. Neutrophil membrane sulfhydryl groups are involved in stimulated neutrophil adherence to endothelium. J Leukoc Biol. 1989;45:177-182.
18. Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem. 2000;275:39964-39972.
19. Yan B, Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry. 2001;40:8861-8867.
20. Essex DW, Chen K, Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood. 1995;86:2168-2173.
21. Essex DW, Li M, Miller A, Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry. 2000;40:6070-6075.
22. Essex DW, Li M. Protein disulfide isomerase mediated platelet aggregation and secretion. Br J Haematol. 1999;104:448-454.
23. O'Neill S, Robinson A, Deering A, Ryan M, Fitzgerald DF, Moran N. The platelet integrin αIIbβ3 has an endogenous thiol isomerase activity. J Biol Chem. 2000;275:36984-36990.
24. Xia Z, Wong T, Liu Q, Kasir-Friede A, Brown E, Frojmovic MM. Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol. 1996;93:204-214.
25. Kehrel B, Wierwille S, Clemetson KJ, et al. Glycoprotein VI is a major collagen receptor for platelet activation. Blood. 1998;91:491-499.
26. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1 independent activation of platelets by simple collagen-like peptides: collagen tertiary and quaternary structures are sufficient alone for α2β1-independent platelet reactivity. Biochemical J. 1995;306:337-344.
27. Aszodi A, Pfeifer A, Ahmad M, et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 1999;18:37-48.
28. Kehrel B, Kronenberg A, Rauterberg J, et al. Platelets deficient in glycoprotein IIIb aggregate normally to collagen type I and III but not to collagen type V. Blood. 1993;82:3364-3370.
29. Dormann D, Clemetson KJ, Kehrel B. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood. 2000;96:2469-2478.
30. Frenette PS, Denis CV, Weiss L, et al. P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interaction in vivo. J Exp Med. 2000;191:1413-1422.
31. Roth RE. Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem Biophys Res Commun. 1981;98:431-438.
32. Mandel R, Ryser HJ, Ghani F, Wu M, Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide isomerase. Proc Natl Acad Sci U S A. 1993;90:4112-4116.
33. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci U S A. 1994;91:4559-4563.
34. Burgess JK, Hotchkiss KA, Suter C, et al. Physical proximity and functional association of glycoprotein Ibα and protein disulfide isomerase on the platelet plasma membrane. J Biol Sci. 2000;275:9758-9766.
35. Frelinger AL, Lam SC, Plow EF, Smith MA, Loftus JC, Ginsberg MH. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem. 1988;263:12397-12402.
36. D'Souza SE, Haas TA, Piotrowicz RS, et al. Ligand and cation binding are dual functions of a discrete segment of the integrin β3 subunit: cation displacement is involved in ligand binding. Cell. 1994;79:659-667.
37. Dickeson SK, Bhattachayya-Pakrasi M, Mathis NL, Schlesinger PH, Santoro SA. Ligand binding results in divalent cation displacement from the α2β1 integrin I domain. Biochemistry. 1998;37:11280-11288.
38. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIB-IIIa complex during platelet activation. J Biol Chem. 1985;260:11107-11114.
39. Lam SC, Plow EF, Ginsberg MH. Platelet membrane glycoprotein IIb heavy chain forms a complex with glycoprotein IIIa that binds Arg-Gly-Asp peptide. Blood. 1989;73:1513-1518.
40. Smyth SS, Tsakiris DA, Scudder LE, Coller BS. Structure and function of murine αIIbβ3 (GPIIbIIIa). Thromb Haemost. 2000;84:1103-1108.
41. Frelinger AL 3rd, Du XP, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin αIIbβ3 alter receptor affinity, specificity, and function. J Biol Chem. 1991;266:17106-17111.